| 1 |
35108536 | Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry. | 2022 Feb 1 |
2 |
| 2 |
33177194 | Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses. | 2021 Jan 13 |
1 |
| 3 |
34659153 | The Role of L-Selectin in HIV Infection. | 2021 |
1 |
| 4 |
34731616 | Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies. | 2021 Nov 2 |
1 |
| 5 |
32179120 | Extraction of polysaccharides from maca: Characterization and immunoregulatory effects on CD4+ T cells. | 2020 Jul 1 |
1 |
| 6 |
32760719 | Targeting of the C-Type Lectin Receptor Langerin Using Bifunctional Mannosylated Antigens. | 2020 |
1 |
| 7 |
33205023 | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies. | 2020 Nov 20 |
1 |
| 8 |
30328700 | Mapping of Neutralizing Antibody Epitopes on the Envelope of Viruses Obtained from Plasma Samples Exhibiting Broad Cross-Clade Neutralization Potential Against HIV-1. | 2019 Feb |
1 |
| 9 |
30729651 | A novel anti-HIV-1 bispecific bNAb-lectin fusion protein engineered in a plant-based transient expression system. | 2019 Aug |
1 |
| 10 |
31466401 | Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination | 2019 Aug 28 |
1 |
| 11 |
31564450 | Antigenicity and immunogenicity of HIV-1 gp140 with different combinations of glycan mutation and V1/V2 region or V3 crown deletion. | 2019 Dec 3 |
2 |
| 12 |
31678713 | Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells. | 2019 Dec |
1 |
| 13 |
29633346 | Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy. | 2018 Sep |
1 |
| 14 |
29963041 | Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I. | 2018 |
1 |
| 15 |
30076101 | Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies. | 2018 Aug 21 |
2 |
| 16 |
30395637 | HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. | 2018 Nov |
1 |
| 17 |
27846415 | Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies. | 2017 Jan 15 |
1 |
| 18 |
28279830 | Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction. | 2017 May |
2 |
| 19 |
28287405 | T cells control the generation of nanomolar-affinity anti-glycan antibodies. | 2017 Apr 3 |
1 |
| 20 |
28445724 | Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. | 2017 Apr 25 |
3 |
| 21 |
28632942 | The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation. | 2017 Dec |
18 |
| 22 |
28890362 | Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield. | 2017 Oct 3 |
1 |
| 23 |
27489265 | Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. | 2016 Oct 15 |
4 |
| 24 |
27581986 | Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site. | 2016 Nov 15 |
6 |
| 25 |
26516768 | A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo. | 2015 Oct |
2 |
| 26 |
25253346 | Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. | 2014 Dec |
2 |
| 27 |
25263953 | Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. | 2014 Dec |
1 |
| 28 |
23158834 | Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation. | 2013 Sep |
1 |
| 29 |
23525136 | Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines. | 2013 Feb 1 |
1 |
| 30 |
23658524 | Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. | 2013 |
1 |
| 31 |
23874792 | The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody. | 2013 |
1 |
| 32 |
24174970 | O-glycosylation of NnTreg lymphocytes recognized by the Amaranthus leucocarpus lectin. | 2013 |
1 |
| 33 |
24204277 | Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. | 2013 Oct |
1 |
| 34 |
22366522 | Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. | 2012 May 30 |
1 |
| 35 |
22490576 | Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma. | 2012 Mar |
1 |
| 36 |
23088960 | Sialic acid cyclization of human Th homing receptor glycan associated with recurrent exacerbations of atopic dermatitis. | 2012 Dec |
1 |
| 37 |
20473945 | Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. | 2011 Mar 15 |
2 |
| 38 |
21697467 | Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site. | 2011 Sep |
2 |
| 39 |
20610714 | HIV-1 gp120 determinants proximal to the CD4 binding site shift protective glycans that are targeted by monoclonal antibody 2G12. | 2010 Sep |
1 |
| 40 |
20616231 | Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. | 2010 Aug 13 |
3 |
| 41 |
18237398 | The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion. | 2008 Jan 31 |
2 |
| 42 |
18322210 | Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes. | 2008 Mar 15 |
1 |
| 43 |
18385254 | Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop. | 2008 Jun |
1 |
| 44 |
17301214 | A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. | 2007 Apr |
1 |
| 45 |
17947541 | Inhibitory role of CXCR4 glycan in CD4-independent X4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD4-dependent infection. | 2007 Nov |
5 |
| 46 |
16711753 | A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity. | 2006 May-Jun |
1 |
| 47 |
16918445 | Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine. | 2006 Aug |
1 |
| 48 |
16160185 | Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4. | 2005 Oct |
2 |
| 49 |
16275921 | Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. | 2005 Nov 15 |
1 |
| 50 |
15163414 | Polysaccharide processing and presentation by the MHCII pathway. | 2004 May 28 |
1 |